GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (WBO:GLPG) » Definitions » Market Cap

Galapagos NV (WBO:GLPG) Market Cap : €1,758.1 Mil (As of Apr. 29, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Galapagos NV Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Galapagos NV's share price for the quarter that ended in Dec. 2023 was €37.06. Galapagos NV's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 65.9 Mil. Therefore, Galapagos NV's market cap for the quarter that ended in Dec. 2023 was €2,442.1 Mil.

Galapagos NV's quarterly market cap declined from Jun. 2023 (€2,462.6 Mil) to Sep. 2023 (€2,141.7 Mil) but then increased from Sep. 2023 (€2,141.7 Mil) to Dec. 2023 (€2,442.1 Mil).

Galapagos NV's annual market cap declined from Dec. 2021 (€3,165.5 Mil) to Dec. 2022 (€2,734.8 Mil) and declined from Dec. 2022 (€2,734.8 Mil) to Dec. 2023 (€2,442.1 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Galapagos NV's Enterprise Value for Today is €-1,916.8 Mil.


Galapagos NV Market Cap Historical Data

The historical data trend for Galapagos NV's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Market Cap Chart

Galapagos NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,125.03 5,294.43 3,165.54 2,734.81 2,442.15

Galapagos NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,734.81 2,279.38 2,462.57 2,141.66 2,442.15

Competitive Comparison of Galapagos NV's Market Cap

For the Biotechnology subindustry, Galapagos NV's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galapagos NV's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galapagos NV's Market Cap distribution charts can be found below:

* The bar in red indicates where Galapagos NV's Market Cap falls into.



Galapagos NV Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Galapagos NV's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€37.06*65.8971
=€2,442.1

Galapagos NV's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=€37.06*65.8971
=€2,442.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Galapagos NV  (WBO:GLPG) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Galapagos NV Market Cap Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Galapagos NV (WBO:GLPG) Business Description

Address
Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.